Monday, June 20, 2016
- 12:30pm-2:00pm
-
Variability in the ideal target of GPi DBS for Parkinson’s disease requires advanced direct targeting for optimal results
- 12:30pm-2:00pm
-
Verb naming in hypokinetic and hyperkinetic movement disorders: Preliminary results
Parkinson's disease: Non-motor symptoms · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
Vocal fold augmentation in patients with Parkinson’s disease: A case series and review of the literature
Parkinson's disease: Non-motor symptoms · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
VOP/ZI deep brain stimulation for the relief of tremor in multiple sclerosis
Surgical therapy: Other movement disorders · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
Wearable sensors and decision algorithms for advanced therapy referral in Parkinson’s disease
- 12:30pm-2:00pm
-
Weight changes in PD patients post-DBS: A look at the factors involved
Surgical therapy: Parkinson's disease · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
When DBS can be of benefit in Huntington’s disease
Surgical therapy: Other movement disorders · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
Work-related stress and risk for Parkinson’s disease
Epidemiology · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
Zolpidem ameliorates the freezing of gait in a patient with PAGF (pure akinesia with freezing of gait)-the possible neural mechanism
Parkinsonism, MSA, PSP (secondary and parkinsonism-plus) · Exhibit Hall located in Hall B, Level 2